(Q34169255)

31 July 2017

1 reference

title

Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? (English)

1 reference

cost-effectiveness analysis

31 July 2017

1 reference

1 reference

Nathwani D

1

1 reference

31 July 2017

Rubinstein E

series ordinal

2

1 reference

31 July 2017

Barlow G

series ordinal

3

1 reference

31 July 2017

Davey P

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 February 2001

1 reference

Clinical Infectious Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

32

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

728-741

1 reference

Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective

31 July 2017

cites work

1 reference

Antimicrobial misuse in patients with positive blood cultures.

21 January 2018

1 reference

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

21 January 2018

1 reference

Community-acquired pneumonia guidelines--an international comparison: a view from Europe.

21 January 2018

1 reference

How to ensure that guidelines are effective

21 January 2018

1 reference

Measuring Quality of Care

21 January 2018

1 reference

Why don't physicians follow clinical practice guidelines? A framework for improvement

21 January 2018

1 reference

Clinical guidelines: proliferation and medicolegal significance

21 January 2018

1 reference

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

21 January 2018

1 reference

Frequency of subspecialty physician care for elderly patients with community-acquired pneumonia

21 January 2018

1 reference

Use of investigations in lower respiratory tract infection in the community: a European survey

21 January 2018

1 reference

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

21 January 2018

1 reference

Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination

21 January 2018

1 reference

Clinical signs of pneumonia in children

21 January 2018

1 reference

Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.

21 January 2018

1 reference

Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors

21 January 2018

1 reference

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

21 January 2018

1 reference

Comparison of physician judgment and decision aids for ordering chest radiographs for pneumonia in outpatients

21 January 2018

1 reference

Older persons' perceptions of home and hospital as sites of treatment for acute illness

21 January 2018

1 reference

Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

21 January 2018

1 reference

Pediatricians' attitudes, beliefs, and practices regarding clinical practice guidelines: a national survey

21 January 2018

1 reference

Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system

21 January 2018

1 reference

Quality of care, process, and outcomes in elderly patients with pneumonia

21 January 2018

1 reference

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia

21 January 2018

1 reference

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients

21 January 2018

1 reference

Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study.

21 January 2018

1 reference

Role of pharmacokinetics in the outcome of infections

21 January 2018

1 reference

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia

21 January 2018

1 reference

Clinical implications of positive blood cultures

21 January 2018

1 reference

Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism "Z".

21 January 2018

1 reference

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

21 January 2018

1 reference

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

21 January 2018

1 reference

On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome.

21 January 2018

1 reference

Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia

21 January 2018

1 reference

Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?

21 January 2018

1 reference

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

21 January 2018

1 reference

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

21 January 2018

1 reference

The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy

21 January 2018

1 reference

Improving drug prescribing in primary care: a critical analysis of the experimental literature

21 January 2018

1 reference

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

21 January 2018

1 reference

Use of a treatment protocol in the management of community-acquired lower respiratory tract infection

21 January 2018

1 reference

Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection

21 January 2018

1 reference

Why is evaluation of the cost effectiveness of audit so difficult? The example of thrombolysis for suspected acute myocardial infarction

21 January 2018

1 reference

A prospective, multicenter study of a pneumonia practice guideline.

21 January 2018

1 reference

All changed, changed utterly. British medicine will be transformed by the Bristol case

21 January 2018

1 reference

Enhancing performance measurement: NCQA's road map for a health information framework. National Committee for Quality Assurance

21 January 2018

1 reference

Intravenous antimicrobial therapy in the community: underused, inadequately resourced, or irrelevant to health care in Britain?

21 January 2018

1 reference

A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines.

21 January 2018

1 reference

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

21 January 2018

1 reference

Hospitalized pneumonia. Outcomes, treatment patterns, and costs in urban and rural areas

21 January 2018

1 reference

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/319216

1 reference

31 July 2017

1 reference